Targeting mitochondrial ROS-CK2-SET-PP2A pathway with ceria nanoparticles to reverse Tau pathology in APOEε4-associated Alzheimer’s disease [scRNA-seq]
Ontology highlight
ABSTRACT: In this study, we used triphenylphosphonium-conjugated ceria nanoparticles (Ceria-TPP) to target mitochondrial ROS in APOEε4 human iPSC-derived brain organoid, and profiled transcriptional changes via single-cell RNA-seq.
ORGANISM(S): Homo sapiens
PROVIDER: GSE334035 | GEO | 2026/06/07
REPOSITORIES: GEO
ACCESS DATA